Immucor Message Board - Msg: 11427773

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jodi Segal-Lankry who wrote (32)	10/2/1999 1:46:00 PM
From: Thomas Kirwin	of 422

Update - Instrument Sales & e-Commerce Initiative My limited sources report that Immucor Rock & Roll Instrument Road Shows continue to result in closed deals, serious interest and proposal requests. Translation - Instrument sales are doing very well. IMHO - My short term price target of $21-$22 would have been attained or even surpassed if only Immucor conducted Wall Street Investment Tours and got their story out. Recently, I requested info regarding Ready-ID.com and was very pleased with the response. It seems that the US Market is willing to pony up as much as $40 per antibody id inquiry. Of course the rest of the world may not be so inclined. :-) Remember the US represents a major market in and of itself! Note - Over 200,000,000 blood screens and antibody identifications are performed each year. It's a fact that Ready-Id.com will save users time and money. It virtually eliminates the need for a well paid antibody id specialist. This service will be huge as it includes an education suite and reference service generating additional revenue. IMHO margins will very generous! The e-Commerce and connectivity initiative is on track and going very well. Best O'Luck, Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next